Bio-Techne retention bonuses approved for Kim Kelderman, Jim Hippel
I'm LongbridgeAI, I can summarize articles.Bio-Techne approved cash retention bonuses for five named executive officers, including Kim Kelderman and Jim Hippel, in connection with a contemplated merger. The bonuses, ranging from approximately $910,000 to $2.1 million, are designed to encourage retention until the merger's effective date of June 23, 2026. Payments are contingent upon continued employment or qualifying termination and the execution of a release.
Bio-Techne approved cash retention bonuses for named executive officers in connection with the contemplated merger.
| Individual | Kim Kelderman | Jim Hippel | William Geist | Shane Bohnen | Steve Crouse |
| Role | Named executive officer | Named executive officer | Named executive officer | Named executive officer | Named executive officer |
| Type of Change | Retention bonus approved | Retention bonus approved | Retention bonus approved | Retention bonus approved | Retention bonus approved |
| Effective Date | June 23, 2026 (effective upon execution of Merger Agreement) | June 23, 2026 (effective upon execution of Merger Agreement) | June 23, 2026 (effective upon execution of Merger Agreement) | June 23, 2026 (effective upon execution of Merger Agreement) | June 23, 2026 (effective upon execution of Merger Agreement) |
| Reason | To encourage retention and continued performance until the Effective Time | To encourage retention and continued performance until the Effective Time | To encourage retention and continued performance until the Effective Time | To encourage retention and continued performance until the Effective Time | To encourage retention and continued performance until the Effective Time |
| Replacement Info | Not disclosed | Not disclosed | Not disclosed | Not disclosed | Not disclosed |
| Background Details | Retention agreement provides $2,120,976 lump sum; payable on Vesting Date subject to employment or Qualifying Termination and release execution | Retention agreement provides $1,541,510 lump sum; payable on Vesting Date subject to employment or Qualifying Termination and release execution | Retention agreement provides $1,161,014 lump sum; payable on Vesting Date subject to employment or Qualifying Termination and release execution | Retention agreement provides $971,097 lump sum; payable on Vesting Date subject to employment or Qualifying Termination and release execution | Retention agreement provides $910,263 lump sum; payable on Vesting Date subject to employment or Qualifying Termination and release execution |
| Board/Committee Role Changes | Not disclosed | Not disclosed | Not disclosed | Not disclosed | Not disclosed |
Original SEC Filing: BIO-TECHNE Corp [ TECH ] - 8-K - Jun. 25, 2026
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.